BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li X, Xie M, Yin S, Xiong Z, Mao C, Zhang F, Chen H, Jin L, Lan P, Lian L. Identification and Validation of a Six Immune-Related Genes Signature for Predicting Prognosis in Patients With Stage II Colorectal Cancer. Front Genet 2021;12:666003. [PMID: 34017356 DOI: 10.3389/fgene.2021.666003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Li L, Chu F, Zhang L, Zhang L, Wu H, Li K. The tumor microenvironment in gastrointestinal adenocarcinomas revealed a prognostic and immunotherapeutic biomarker. Aging (Albany NY) 2022;14:10171-216. [PMID: 36585927 DOI: 10.18632/aging.204463] [Reference Citation Analysis]
2 Zhang Q, Wang Y, Xue F, Singh K. ASPM, CDC20, DLGAP5, BUB1B, CDCA8, and NCAPG May Serve as Diagnostic and Prognostic Biomarkers in Endometrial Carcinoma. Genetics Research 2022;2022:1-18. [DOI: 10.1155/2022/3217248] [Reference Citation Analysis]
3 Zhan L, Sun C, Zhang Y, Zhang Y, Jia Y, Wang X, Li F, Li D, Wang S, Yu T, Zhang J, Li D. Four methylation-driven genes detected by linear discriminant analysis model from early-stage colorectal cancer and their methylation levels in cell-free DNA. Front Oncol 2022;12:949244. [DOI: 10.3389/fonc.2022.949244] [Reference Citation Analysis]
4 Luo Y, Chen R, Ning Z, Fu N, Xie M. Identification of a Four-Gene Signature for Determining the Prognosis of Papillary Thyroid Carcinoma by Integrated Bioinformatics Analysis. IJGM 2022;Volume 15:1147-60. [DOI: 10.2147/ijgm.s346058] [Reference Citation Analysis]